Tempus has built the world’s largest library of clinical & molecular data and an operating system to make that data accessible and useful, starting with cancer.

Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, [5] for oncology, cardiology, radiology, and depression. The company went public on the …

Jan 11, 2026 · Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.

Jan 15, 2026 · JPM26: Tempus AI and the push toward precision medicine Founded in 2015, Tempus built a platform designed to turn real-world clinical information into structured, centralised, and …

Jan 13, 2026 · Chicago artificial intelligence giant Tempus AI is showing it's operating in the black after 10 years and growing.

Jan 1, 2026 · Tempus Unlimited exists to provide a continuum of community based services that support the efforts of children and adults with disabilities to live as independently as possible in the least …

TEMPUS® is a technology company that has built the world's largest library of clinical and molecular data and an operating system to make that information accessible and useful for patients, physicians …

3 days ago · Tempus AI, Inc. TEM has achieved several significant milestones over the past year. The company recorded Total Contract Value (“TCV”) of more than $1.1 billion as of Dec. 31, 2025. It …

2 days ago · Tempus AI's diagnostics segment shows strong pricing power, with Oncology ASP rising from $1,630 to over $2,200. Read why TEM stock is a Strong Buy.

Approval of the financial assistance application is based on the applicable billing laboratory's financial assistance program. Your eligibility for financial assistance may vary depending on the applicable …